Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Quark Pharmaceuticals, Inc.

http://www.quarkpharma.com/

Latest From Quark Pharmaceuticals, Inc.

IPOs Are Back: Liquid Biopsy, Cardio, Dialysis Firms Lead $1.5Bn Charge

Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.

Financing Analysis

Renalytix AI And AstraZeneca Collaborate To Improve Chronic Kidney Disease Outcomes

The companies will launch "precision medicine strategies" for chronic disease that use Renalytix' AI-enabled IVDs.

Deals Artificial Intelligence

Renalytix AI Launches Trial To Identify COVID-19 Patients With Kidney Injury

The Mount Sinai spin-off believes its KindeyIntelX system can identify COVID-19 patients at high risk for long-term kidney damage.

Coronavirus COVID-19 In Vitro Diagnostics

Regulatory, Security Concerns Force Wuxi NextCODE To Cut China Ties

As China tightens its grip over clinical research using human genetic data in the country, and the US increases scrutiny over the use of personal data, multinational drug developers may face a difficult choice or even create separate entities to cater to local regulatory requirements. WuXi NextCODE provides one interesting case study. 

Regulation Legislation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
UsernamePublicRestriction

Register